NONE

Company

ROCKET PHARMACEUTICALS, INC.

Filed

September 20, 2017

Accession Number

0001140361-17-036028

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →